Hair loss is one of the most distressing side-effects of chemotherapy. Thanks to a generous donation, patients at the Chartwell Unit at Princess Royal University Hospital can now get the help of a new generation of cold caps, which have led to better results and a more comfortable experience for patients.

Chemotherapy fights cancer by targeting all rapidly dividing cells in the body. But because hair cells divide quickly, they come under attack – meaning hair can start to fall out within two weeks of treatment starting. Scalp-cooling reduces blood flow to hair follicles by up to 40%, preventing or minimising hair loss.

The old cooling machines required very low temperatures to be effective and didn’t always fit properly. The South East London Breast Cancer Trust, a charity founded by former patients, stepped in with a donation to buy three Paxman Orbis 2 scalp-cooling machines.


“It made a big difference", said matron for oncology, Catherine McGarry. "The newer cold caps fit much better, while the machines operate at three degrees higher than the old ones, which means more people can tolerate them.
"And because they don’t take so long to reach the required temperature, patients don’t have to stay here so long. Anything we can do to reduce the amount of time our patients spend here – while ensuring they receive the best treatment quickly and safely – is of enormous value.”
“Being able to offer scalp-cooling means we can help patients regain some control and maintain their privacy while encouraging a positive attitude towards cancer treatment overall. It means people don’t have to travel far and can have the very best treatment closer to home.”


The generosity of donors also enabled the unit to buy some much-needed extra computer equipment, two PCs and a laptop. 
“Each patient’s chemotherapy regime needs to be carefully checked and documented before and during treatment", said Catherine. "We simply didn’t have enough computers to do this efficiently, which resulted in increased waiting times and added stress for patients.”